Source: Health Products and Food Branch (CA) Revision Year: 2020
MOTRIN.
| Route of Administration | Oral Dosage Form / Strength | Clinically Relevant Nonmedicinal Ingredients |
|---|---|---|
| Oral | Tablet/200 mg | None For a complete listing see Dosage Forms, Composition and Packaging section. |
| Oral | Tablet/300 mg | None For a complete listing see Dosage Forms, Composition and Packaging section. |
| Oral | Tablet/400 mg | None For a complete listing see Dosage Forms, Composition and Packaging section. |
MOTRIN 200 mg is available as white, sweet-coated biconvex tablets, with “Motrin IB” printed in black ink, in bottles of 24, 90 and 150.
MOTRIN 200 mg contains ibuprofen 200 mg and the following non-medicinal ingredients in alphabetical order: colloidal silicon dioxide, corn starch, hypromellose, iron oxide black, polyethylene glycol, pregelatinized starch, propylene glycol, sodium cyclamate, sodium starch glycolate, stearic acid and titanium dioxide.
MOTRIN 300 mg is available as solid, light orange coloured, round, biconvex, sweet-coated tablets, with ‘MOTRIN 300 mg’ printed in black ink, in bottles of 60.
MOTRIN 300 mg contains ibuprofen 300 mg and the following non-medicinal ingredients in alphabetical order: carnauba wax, colloidal silicon dioxide, corn starch, FD&C yellow no. 6, hypromellose, iron oxide black, polydextrose, polyethylene glycol, propylene glycol, sodium cyclamate, sodium starch glycolate, stearic acid, titanium dioxide.
MOTRIN 400 mg is available as solid, orange coloured, round, biconvex, sweet-coated tablets, with ‘MOTRIN 400 mg’ printed in black ink, in bottles of 16 and 45.
MOTRIN 400 mg contains ibuprofen 400 mg and the following non-medicinal ingredients in alphabetical order: carnauba wax, colloidal silicon dioxide, corn starch, FD&C yellow no. 6, hypromellose, iron oxide black, polydextrose, polyethylene glycol, propylene glycol, sodium cyclamate, sodium starch glycolate, stearic acid, titanium dioxide.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
McNeil Consumer Healthcare, Division of Johnson & Johnson Inc., 88 McNabb Street, Markham, Canada, L3R 5L2 237424 |
Date of approval:
Last Approved: February 26, 2015 June 18, 2020 |
| Drug | Countries | |
|---|---|---|
| MOTRIN | Brazil, Canada, Ecuador, Mexico, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
